Neuronetics' strategic acquisitions, including Greenbrook, and FDA approvals are expected to drive revenue growth. See why ...

The U.S. government slashing spending and the slump in mega-cap technology stocks are among the five major secular inflection ...

Please give us a brief overview of the sectors and any subsectors you cover. Mr. Snyder: I cover U.S. multi-industry here at Morgan Stanley. All of the industrial verticals roll up into my coverage.